AIMD - Ainos, Inc.
1.38
-0.090 -6.522%
Share volume: 24,707
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$1.47
-0.09
-0.06%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-05-2024 | 11-06-2024 | 03-07-2025 | 05-14-2025 | 08-13-2025 | 11-13-2025 | |
| Assets | ||||||||
| Total Assets | 29.754 M | 35.539 M | 31.370 M | 28.820 M | 26.353 M | 23.922 M | 22.679 M | |
| Current Assets | 1.509 M | 8.472 M | 5.649 M | 4.338 M | 3.051 M | 1.734 M | 1.721 M | |
| Inventories | 169.655 K | 166.322 K | 160.701 K | 143.756 K | 141.831 K | 160.057 K | 166.883 K | |
| Other Current Assets | 304.608 K | 291.166 K | 331.898 K | 301.077 K | 280.784 K | 350.549 K | 425.753 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.031 M | 8.014 M | 5.157 M | 3.893 M | 2.628 M | 1.223 M | 1.128 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 768.665 K | 691.100 K | 649.063 K | 559.645 K | 494.387 K | 495.109 K | 414.558 K | |
| Other Assets | 27.476 M | 26.377 M | 25.071 M | 23.923 M | 22.808 M | 21.693 M | 20.544 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 29.754 M | 35.539 M | 31.370 M | 28.820 M | 26.353 M | 23.922 M | 22.679 M | |
| Total liabilities | 7.076 M | 14.827 M | 13.348 M | 13.304 M | 13.231 M | 12.479 M | 12.634 M | |
| Total current liabilities | 4.706 M | 5.743 M | 4.131 M | 3.955 M | 1.523 M | 602.782 K | 581.356 K | |
| Accounts Payable | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 2.370 M | 83.912 K | 216.760 K | 348.945 K | 707.957 K | 876.608 K | 1.053 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 9.000 M | 9.000 M | 9.000 M | 11.000 M | 11.000 M | 11.000 M | |
| Other liabilities | 2.370 M | 83.912 K | 216.760 K | 348.945 K | 707.957 K | 876.608 K | 1.053 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 22.679 M | 20.712 M | 18.022 M | 15.516 M | 13.122 M | 11.443 M | 10.045 M | |
| Common stock | 64.215 M | 65.489 M | 66.362 M | 68.675 M | 69.607 M | 71.711 M | 73.311 M | |
| Retained earnings | -41.201 M | -44.396 M | -48.095 M | -52.749 M | -56.035 M | -60.120 M | -63.052 M |